Filing Details
- Accession Number:
- 0001181431-11-057051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-21 12:06:07
- Reporting Period:
- 2011-11-18
- Filing Date:
- 2011-11-21
- Accepted Time:
- 2011-11-21 12:06:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
722104 | Savient Pharmaceuticals Inc | SVNT | Medicinal Chemicals & Botanical Products (2833) | 133033811 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1410781 | John Johnson | Savient Pharmaceuticals, Inc. One Tower Center, 14Th Floor East Brunswick NJ 08816 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value Per Share | Acquisiton | 2011-11-18 | 1,000 | $2.36 | 4,000 | No | 4 | P | Indirect | By son |
Common Stock, $.01 Par Value Per Share | Acquisiton | 2011-11-18 | 10,000 | $2.28 | 265,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By son |
No | 4 | P | Direct |
Footnotes
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.